You are viewing a free summary from Descrybe.ai. For citation checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.

Acuity v. Masters Pharmaceuticals, Inc.

Citation: 2022 Ohio 3092Docket: 2020-1134

Court: Ohio Supreme Court; September 7, 2022; Ohio; State Supreme Court

Original Court Document: View Document

Narrative Opinion Summary

The Supreme Court of Ohio addressed whether Acuity, an insurer, had a duty to defend Masters Pharmaceutical, Inc. in lawsuits filed by governmental entities seeking economic damages related to the opioid crisis. The central issue revolved around whether the claims constituted 'damages because of bodily injury' under the commercial general liability policies held by Masters between 2010 and 2018. The trial court initially ruled in favor of Acuity, citing that the claims were for economic losses and not specifically for bodily injuries, and that Masters was aware of the crisis prior to the policy periods, invoking the loss-in-progress provision to deny coverage. However, the First District Court of Appeals reversed this decision, suggesting that some economic damages, such as medical expenses, could be linked to bodily injury and that ambiguities should be resolved in favor of Masters. Upon further appeal, the Supreme Court reinstated the trial court's decision, emphasizing that the claims did not fall within the scope of 'damages because of bodily injury,' as they sought compensation for public nuisance and economic losses rather than specific injuries. The ruling clarified the requirement for a direct causal link between bodily injury and damages under the policy, ultimately concluding that Acuity had no obligation to defend Masters in these lawsuits. Justice Stewart dissented, advocating for a broader interpretation of the policy language in favor of the insured.

Legal Issues Addressed

Ambiguity in Insurance Contracts

Application: Justice Stewart dissented, arguing that ambiguous provisions should be interpreted in favor of the insured, suggesting that Acuity's duty to defend was triggered.

Reasoning: Justice Stewart dissents, arguing that Acuity’s duty to defend was triggered by the lawsuits from various cities and counties seeking damages related to opioid addiction treatment.

Duty to Defend under Commercial General Liability Policies

Application: The court ruled that Acuity is not obligated to defend Masters Pharmaceutical, Inc. in lawsuits brought by governmental entities seeking economic damages related to the opioid epidemic, as these claims do not fall under 'damages because of bodily injury.'

Reasoning: Acuity, the insurer for Masters Pharmaceutical, Inc., is not obligated to defend Masters in lawsuits brought by various governmental entities seeking economic damages related to the opioid epidemic.

Interpretation of 'Damages Because of Bodily Injury'

Application: The court emphasized that a direct causal relationship is required between the bodily injury and the damages sought, rejecting a broad interpretation that encompasses economic costs unrelated to specific bodily injuries.

Reasoning: The court declines this expansive interpretation, emphasizing that the ordinary meaning of 'because of' implies a direct causal relationship.

Loss-in-Progress Provision

Application: The court determined that Masters was aware of the opioid crisis before acquiring the insurance policies, invoking the loss-in-progress provision to deny coverage.

Reasoning: The trial court ruled in favor of Acuity, determining that the claims did not seek damages for bodily injury and that Masters was aware of the bodily injuries prior to the policy period, thus citing loss-in-progress provisions to deny coverage.

Public Nuisance and Economic Loss Claims

Application: Claims by governmental entities related to the opioid epidemic are characterized as seeking recovery for public nuisance and economic losses, which are not considered 'damages because of bodily injury' under the policy.

Reasoning: Governments have filed claims against Masters for public nuisance, negligence, and RICO Act violations, alleging that his actions exacerbated the opioid epidemic, leading to significant economic losses for the governments...